Intelligence Platform

Patents

Browse 1,015 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 9868774

Anti-CD22 chimeric antigen receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9868961

Methods and compositions for localized secretion of anti-CTLA-4 antibodies

The Regents of the University of California · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9855291

Anti-kidney associated antigen 1 (KAAG1) antibodies

ADC THERAPEUTICS SA · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9840559

Anti-CD83 antibodies and use thereof

The Regents of the University of California · Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9840557

Anti-IL-25 antibodies and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9833427

Creatine ester anti-inflammatory compounds and formulations

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9827310

Anti-ErbB3 antibodies and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9822162

Anti-human papillomavirus 16 E6 T cell receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9803021

CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities

The Regents of the University of California · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9790281

Humanized anti-CD134 (OX40) antibodies and uses thereof

Biocerox Products B.V. · Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9789184

Anti-EGFR antibodies and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9790285

Anti-CD38 antibodies

Takeda Pharmaceutical Company Limited · Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9790273

Anti-HLA-B*27 antibodies and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9782428

Method for generation of broadly neutralizing anti-pathogen antibodies

Northwestern University · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9770414

Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (D

Pacira Pharmaceuticals, Inc. · Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9765147

Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer

Five Prime Therapeutics, Inc. · Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9751932

Anti-big-endothelin-1 (big-ET-1) antibodies and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9745376

Anti-ανβ6 antibodies

The Regents of the University of California · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9737477

Anti-aging dietary composition containing polysaccharides derived from ginseng and tuber f

INFINITUS (CHINA) COMPANY LTD. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9732114

Compounds having anti-adhesive effects on cancer cells

The Board of Regents of the University of Texas System · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9725475

Arsenoplatin anti-cancer agents

Northwestern University · Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9718881

Anti-Activin A antibodies and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9707262

Composition with anoxia-tolerant and anti-fatigue effects and use thereof

INFINITUS (CHINA) COMPANY LTD. · Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9701758

Anti-CD19 scFv (FMC63) polypeptide

The Board of Regents of the University of Texas System · Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)